XML 96 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Options and Stock Appreciation Rights - SARs (Details) - Stock Appreciation Rights - USD ($)
12 Months Ended
Apr. 18, 2022
Dec. 31, 2022
Stock option details    
Shares available for future grants 750,000  
Maximum exercisable period for granted share-based compensation 10 years  
Number of rights issued   502,250
Base value of units issued (per unit)   $ 39.95
Vesting period 8 years  
SARs    
Granted   502,250
Foreited   13,000
Outstanding ending balance   489,250
Weighted average exercise price    
Weighted average exercise price, granted (per share)   $ 39.95
Weighted average exercise price, forfeited (per share)   39.33
Weighted average exercise price, ending balance (per share)   $ 39.35
Aggregate intrinsic value    
Aggregate intrinsic value   $ 3,136,000
Weighted average remaining contractual term (years)   9 years 6 months
Fair Value of Liability   $ 546,000
Stock-based compensation expense   $ 546,000